Anti-Human/Rat DFNA5 Polyclonal Antibody

Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene.
List Price: $398
  • Buy 5 for $378.1 each and save 5%
  • Buy 21 for $358.2 each and save 10%
  • Buy 31 for $338.3 each and save 15%
  • Buy 51 for

Properties

Data Sheet Click for Datasheet
Catalog Number PA06215
Size 100μl
Host Type Rabbit
Immunogen Synthesized peptide derived from the Internal region of human DFNA5
Specificity Expressed in cochlea. Low level of expression in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas, with highest expression in placenta.
Isotype IgG
Reacitivity Human,Rat
Clone
Uniprot O60443
Concentration 1mg/mL
Dilution WB 1:500-1:2000, ELISA 1:40000
Formulation
Application WB,ELISA
Other Names 2310037D07Rik,4932441K13Rik,Deafness,autosomal dominant 5,Deafness,autosomal dominant 5 protein,DFNA5,DFNA5 gene,DFNA5,Dfna5h,EG14210,Fin15,ICERE 1,ICERE-1,Inversely correlated with estrogen receptor expression 1,Non-syndromic hearing impairment protein 5,Nonsyndromic hearing impairment protein
Storage Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C.
Postscript For research use only, not for use in diagnostic procedures.

© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap